Zevra Therapeutics Stock (NASDAQ: ZVRA) stock price, news, charts, stock research, profile.
You can purchase shares of Zevra Therapeutics (NASDAQ:ZVRA) through any online brokerage.
Other companies in Zevra Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
Zevra Therapeutics has a consensus price target of $21.00.
The stock price for Zevra Therapeutics (NASDAQ: ZVRA) is $8.72 last updated December 20, 2024 at 7:23 PM EST.
There are no upcoming dividends for Zevra Therapeutics.
Zevra Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Zevra Therapeutics.
Zevra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.